-
Nanostim Signs Investment Agreement with St. Jude Medical (STJ)
Tuesday, May 3, 2011 - 8:03am | 65Nanostim, Inc., a privately-owned developer of miniaturized, leadless pacemakers, today announced that they have reached an agreement under which St. Jude Medical, Inc. (NYSE: STJ) has committed to a staged financing of Nanostim, subject to the company achieving certain development and clinical...
-
Piper Jaffray Maintains Overweight on Cutera (CUTR)
Tuesday, May 3, 2011 - 7:32am | 135Piper Jaffray is out with its report today on Cutera (NASDAQ: CUTR), maintaining Overweight. In a note to clients, Piper Jaffray writes, "CUTR's miss on revenues drove a greater loss per share than expected. Inability to ship through Japan's customs due to the disaster was responsible for about $...
-
Piper Jaffray Raises PT To $26 On Hologic
Tuesday, May 3, 2011 - 7:32am | 125Piper Jaffray, citing strong 2Q11 results, has raised its price target on Hologic Inc. (NASDAQ: HOLX) from $24 to $26. Says Piper Jaffray, in the report, “Hologic reported strong 2Q11 results, with revenue and EPS both exceeding our and Street consensus expectations. Interest in 3D tomosynthesis...
-
Goldman Sachs Raises HOLX Target From $25 To $26
Tuesday, May 3, 2011 - 7:18am | 27Goldman Sachs is raising its PT on shares of Hologic Inc. (NASDAQ: HOLX) from $25 to $26. Hologic closed Monday at $22.42.
-
Morgan Stanley Confirms Stable Trends On Hologic (HOLX)
Tuesday, May 3, 2011 - 6:16am | 96Morgan Stanley provided color on Hologic (NASDAQ: HOLX) in a research report published today. In the report, Morgan Stanley states, "Admittedly, many aspects of the business are beginning to stabilize, but visibility still remains clouded on the outlook for acquisition driven pipeline products,...
-
Piper Jaffray Raises PT On Hologic To $26
Tuesday, May 3, 2011 - 5:59am | 26Piper Jaffray has raised the price target on Hologic (NASDAQ: HOLX) from $24 to $26 and maintains its Overweight rating.
-
Jefferies Raises PT on Hologic To $26
Tuesday, May 3, 2011 - 5:45am | 26Jefferies & Company has raised the price target on Hologic (NASDAQ: HOLX) from $25 to $26 and maintains its Buy rating.
-
Integrating Options into "Sell in May & Go Away" 05-02-2011
Monday, May 2, 2011 - 6:31pm | 904Cusick's Corner What I do not like about the short-term action is that the market has been unable to hold the gains that we started off with and that we have had almost a week of indecision. Could this be the May syndrome of "Sell in May and Go Away"? If you sell in May and come back in September...
-
Hologic Guides FY 2011 EPS $1.24-$1.26 vs. $1.23 Estimate (HOLX)
Monday, May 2, 2011 - 4:03pm | 17Hologic (NASDAQ: HOLX) Guides FY 2011 EPS $1.24-$1.26 vs. $1.23 Estimate
-
Hologic Reports EPS of $0.30 vs. $0.28 Estimate; Revenues $438.7M vs. $433.21M Estimate (HOLX)
Monday, May 2, 2011 - 4:02pm | 21Hologic (NASDAQ: HOLX) Reports EPS of $0.30 vs. $0.28 Estimate; Revenues $438.7M vs. $433.21M Estimate
-
CEOWORLD Top Medical Equipment and Supplies stocks- ELOS, FLDM, SURG, WWIN, KH, OSUR, AIS, TRNX, DCTH, ICUI
Monday, May 2, 2011 - 2:38pm | 1531ICU Medical, Incorporated (NASDAQ:ICUI)- ICU Medical, Inc. is engaged in the development, manufacture and sale of disposable medical connection systems for use in vascular therapy applications. The Company' devices are designed to protect patients from catheter-related bloodstream infections and...
-
Piper Jaffray Reiterates Overweight Rating On BAX
Monday, May 2, 2011 - 10:01am | 149Piper Jaffray is reiterating its OW rating on shares of Baxter International Inc. (NYSE: BAX). “The consent agreement with the FTC requiring the sale of a portion of Talecris' assets is not so unexpected and could create an opportunity for Baxter and other competitors like CSL,” Piper Jaffray...
-
Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve Mapping Catheter
Monday, May 2, 2011 - 9:00am | 123Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration approval for use, and the first patient procedure using the Achieve™ Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating...
-
Wedbush Reiterates Outperform on Varian Medical Systems (VAR)
Monday, May 2, 2011 - 8:14am | 133Wedbush is out with its report today on Varian Medical Systems (NYSE: VAR), reiterating Outperform. In a note to clients, Wedbush writes, "We added Varian Medical to the list of our top recommendations in February because of VAR's leadership in the attractive markets for radiation oncology systems...
-
IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery (IRIX)
Monday, May 2, 2011 - 7:44am | 143IRIDEX Corporation (Nasdaq: IRIX) today announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent applying to a group of specially designed laser handpieces used in invasive ophthalmic surgical procedures. The patent, No. 7,909,816 and titled "Directional Probe Treatment...